Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings

By: via Benzinga
Ahead of Regeneron Pharmaceuticals Inc (NASDAQ: REGN)'s quarterly report, scheduled for Wednesday, Nov. 8, the company's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.